From 2012.igem.org

Revision as of 18:59, 26 September 2012

• Home
• Team
  • The Team
  • Team Registration
• Project
  • 1. Introduction
  • 2. PnA System
  • 3. Virus-Like Particles
    • CCMV
    • HepB
    • Polerovirus Natural BioBrick
  • 4. Outside Modification
  • 5. Inside Modification
  • 6. Detection of VLPs
  • 7. Applications
  • 8. The Constructor
  • 9. Final Overview
• Human Practices
  • Human Practices Home
  • 1. Mini Symposium
  • 2. Visiting Secondary Schools
  • 3. Discovery Festival
    • Communication Science
  • 4. Stakeholders
  • 5. Munich CAS Conference
• Safety
  • Introduction
  • 1. General safety
  • 2. Virus-related safety
  • 3. Regulations
  • 4. Safety suggestions
  • 5. Safety of applications
• Modeling
  • Human Body Model
  • Tertiary folding prediction
  • VLP assembly model
• Attributions
• Parts
• Notebook
  • Journal
  • Protocols

---

Last year's project: Synchronized Oscillatory System

iGEM Home

Contact Us

Our Sponsors:

Purification of VLPs

After production, our sample still contains differnt types of contaminants. To remove the contaminants we build further upon the basic purification protocol that was given to us by Richard Kormelink. We changed the ultracentrifuge and the FPLC for a even more purer sample.

Figure 1: Overview of the purification process

The purification process consists of three parts. The first part is differential centrifugation. It is ultracentrifugation with a sucrose gradient, this technique relies on that smaller particles will get less far through the sucrose solution than larger particles [1]. The result will look like a smear on the side of the vial. We take the lowest part of the smear, in which our VLPs contain. Most of the contaminants in the sample is now removed, to make it purer we load the sample onto a FPLC column. FPLC or Fast Protein Liquid Chromatography is a form of liquid chromatography that is often used for purifying mixtures of proteins [2]. The FPLC can separate proteins on particle size, charge distribution (ion-exchange), hydrophobicity or reverse-phase. We used a column that separate the particles on particle size, these kind of columns do not interact with proteins, so that are particles remain intact.
The output of the FPLC gives us multiple fractions of a few mL. In these fraction our VLPs, aggregates or other proteins are residing. This can be checked with the DLS or if you have calibrated the column it is possible to predict in which fraction the VLPs are [3].

Figure 2: scematic of the FPLC, the solvent is taken up (1), through the degasser (2) and gradient valve (3) by the pump (5) the solvent is then taken through the loop (7) by the valve (6) to take up the sample to load it onto the column (9), the sample is run through the column and is detected by the detector (10) and is analized by the computer (11), the sample itself can be collected (12).

The complete purification methods has so far only being used with the wild type CCMV VLPs in our lab. Multiple variations of CCMV and HepB has been purified only by ultracentrifuge and was in the lab successful.

• Purification protocol CCMV
• Purification protocol HepB

Move further to detection of VLPs

References